<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33596004</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>25</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1537-1611</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of clinical neuromuscular disease</Title><ISOAbbreviation>J Clin Neuromuscul Dis</ISOAbbreviation></Journal><ArticleTitle>Impact of COVID- 19 Infection Among Hospitalized Amyotrophic Lateral Sclerosis Patients.</ArticleTitle><Pagination><StartPage>180</StartPage><EndPage>181</EndPage><MedlinePgn>180-181</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/CND.0000000000000335</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Digala</LastName><ForeName>Lakshmi P</ForeName><Initials>LP</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Missouri Health Care, Columbia, MO.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prasanna</LastName><ForeName>Shivika</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Departments of Health Management &amp; Informatics, Center for Biomedical Informatics, Electrical Engineering &amp; Computer Science, University of Missouri, Columbia, MO.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rao</LastName><ForeName>Praveen</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Departments of Health Management &amp; Informatics, Center for Biomedical Informatics, Electrical Engineering &amp; Computer Science, University of Missouri, Columbia, MO.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Govindarajan</LastName><ForeName>Raghav</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Missouri Health Care, Columbia, MO.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qureshi</LastName><ForeName>Adnan I</ForeName><Initials>AI</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Missouri Health Care, Columbia, MO.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Neuromuscul Dis</MedlineTA><NlmUniqueID>100887391</NlmUniqueID><ISSNLinking>1522-0443</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003428" MajorTopicYN="N">Cross Infection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>R. Govindarajan serves on the advisory board of Alexion Pharmaceuticals, Argenx Pharmaceuticals, Mitsubishi Tanabe Pharmaceuticals, Catalyst pharmaceuticals, Roche pharmaceuticals, Amicus pharmaceuticals, Sarepta pharmaceuticals and has received research support from Alexion Pharmaceuticals, Ra Pharmaceuticals, Strongbridge Pharmaceuticals, American Academy of Neurology, AMARC Enterprises/Poly-MVA, Dysimmune Foundation and InfuCare. He has received speaking honorarium from American Academy of Neurology, Alexion Pharmaceuticals, Mitsubishi Tanabe Pharmaceuticals, Catalyst Pharmaceuticals, Muscular Dystrophy Association and publication honorarium from Springer Publishing, USA, and royalties from CRC press. The remaining authors report no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>17</Day><Hour>14</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33596004</ArticleId><ArticleId IdType="pmc">PMC7892201</ArticleId><ArticleId IdType="doi">10.1097/CND.0000000000000335</ArticleId><ArticleId IdType="pii">00131402-202103000-00010</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cascella M, Rajnik M, Cuomo A, et al. Features, evaluation and treatment coronavirus (COVID-19). In: Statpearls [internet]. Treasure Island, FL: StatPearls Publishing; 2020.</Citation></Reference><Reference><Citation>Mu&#xf1;oz P, Galar A, Catal&#xe1;n P, et al. The first 100 cases of COVID-19 in a Hospital in Madrid with a 2-month follow-up. Rev Esp Quimioter 2020;33:369&#x2013;378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7528411</ArticleId><ArticleId IdType="pubmed">32729288</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehwerhemuepha L, Gasperino G, Bischoff N, et al. HealtheDataLab&#x2013;a cloud computing solution for data science and advanced analytics in healthcare with application to predicting multi-center pediatric readmissions. BMC Med Inform Decis Mak 2020;20:115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7304122</ArticleId><ArticleId IdType="pubmed">32560653</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan WJ, Liang WH, Zhao Y, et al. Comorbidity and its impact on 1590 patients with covid-19 in China: a nationwide analysis. Eur Respir J. 2020;55:2000547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7098485</ArticleId><ArticleId IdType="pubmed">32217650</ArticleId></ArticleIdList></Reference><Reference><Citation>Beltr&#xe1;n-Garc&#xed;a J, Osca-Verdegal R, Pallard&#xf3; FV, et al. Sepsis and coronavirus disease 2019: common features and anti-inflammatory therapeutic approaches. Crit Care Med. 2020;48:1841&#x2013;1844.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7467034</ArticleId><ArticleId IdType="pubmed">32826431</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>